« Street view for the Brain: mapping the connectome | Main | Voice-sensitive region in the dog! »
Wednesday
Mar192014

Drug development for Hep-C

A few years ago, I was in loop with the different competitions going on in the Pharma-world in the race to come up with a cure for the debilitating Hep-C virus. Hep C is simply a virus that destroys the fabric of the Liver, living its victims unable to utilize their Liver for its important functions. The competition was so much, that bigger pharma companies were purchasing smaller drug development companies that they deemed closer to the prized possession of the remedy. It turns out that, there was a lucky winner in the name of “Gilead”. For folks who don’t know much about Gilead, it is a Pharmaceutical company based out of Foster city, California. They develop single tablet regimen for viral diseases that are contagious.

The prized possession part of this write-up, comes in play with the FDA approval of the recently approved single tablet for Hep-C called Solvadi. Solvadi works simply by disrupting the replication mechanism of the Hep-C virus, for other drug regimen to cure the liver. Gilead deems its prized possession has a tremendous breakthrough. It is a tremendous breakthrough. So, Gilead has decided to sell this new drug that could save the lives of 3 million Americans at $1000 per pill. A standard treatment which they asserted will take 12 weeks would cost a whopping $84,000. If a second round of treatment with this drug is needed by a patient, that patient should be ready to cuff out $168,000.

It will be interesting to see how this pricy medication plays out with the health insurance companies. More importantly, it will be interesting to see how other drug development companies react to this gutsy move by Gilead. I am only left with the question “is this going to help shine the light on the pricey tags of drug development, and would it bring about the restructuring of this industry through more regulation.”

Ehimen A

References (8)

References allow you to track sources for this article, as well as articles that were written in response to this article.
  • Response
    go here for best seo espaƱa around
  • Response
    go here for greatest posicionamiento seo barcelona available
  • Response
    click here for greatest agencia de marketing anywhere
  • Response
    Response: sports betting
    Hooker Research Group at MGH Martinos Center - Blog - Drug development for Hep-C
  • Response
    Hooker Research Group at MGH Martinos Center - Blog - Drug development for Hep-C
  • Response
    Hooker Research Group at MGH Martinos Center - Blog - Drug development for Hep-C
  • Response
    Response: on line shop
    Hooker Research Group at MGH Martinos Center - Blog - Drug development for Hep-C
  • Response

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>